{
    "metadata": {
        "title": "Transverse Myelitis in Children \u2022Signs of autonomic dysreflexia include the following:(28) \u2013Elevated blood pressure    \u2013Pounding headache \u2013Bradycardia \u2013Profuse sweating \u2013Piloerection (goose bumps), usually above the level of the lesion but sometimes below \u2013Increased spasticity \u2013Restlessness \u2013Vasoconstriction below level of lesion and vasodilation above level of lesion \u2013Constricted pupils \u2013Nasal congestion \u2013Blurred vision",
        "synonyms": [
            "acute transverse myelitis (atm)",
            "idiopathic transverse myelitis",
            "myelitis",
            " transverse myelopathy"
        ],
        "anatomical location body part affected": [
            "Spinal cord, nervous system"
        ],
        "area of specialty": [
            "neurological rehabilitation",
            "pediatric rehabilitation"
        ],
        "description": [
            "Transverse myelitis (TM) is an inflammation of the spinal cord, typically spanning several vertebral segments, that disrupts ascending and descending neural pathways, causing acute or subacute sensory, motor, and autonomic symptoms(4,24)",
            "TM in children is predominantly idiopathic (in about 60% of cases), indicating that no specific viral or bacterial agent or any known inflammatory cause can be found(4,24)",
            "Diagnostic criteria and a classification scheme for TM were established by the Transverse Myelitis Consortium Working Group of Johns Hopkins Hospital in the United States in 2002(3) \u2013The presence of spinal cord inflammation within 7 days of onset, as defined by cerebrospinal fluid (CSF) pleocytosis, elevated CSF immunoglobulin G index, or gadolinium enhancement on a spinal MRI \u2013Absence of an identified CNS infection \u2013Exclusion of acute myelopathy secondary to a known underlying disease, from the brain, or from compressive spinal cord myelopathies \u2013Clearly defined sensory level impairments peaking between 4 hours and 21 days after initial onset or application of equipment _ _ Provide handouts and websites for patient and caregiver education  Respiratory limitations/ need for mechanical ventilation _ _ Decreased endurance _ _ Orthostatic hypotensionImprove ventilation through various respiratory strategies in conjunction with other healthcare therapists _ _ Improve cardiorespiratory enduranceTherapeutic strategies _ Instruct patient in diaphragmatic breathing and supported cough techniques to improve cardiorespiratory endurance as appropriate _ _ Strengthen accessory respiratory muscles as indicated and encourage the use of a spirometer, if appropriate _ _ Provide chest physical therapy and instruct family members, as indicated _ _ Compression stockings or abdominal binders are two methods of preventing/minimizing orthostatic hypotension _ _ Monitor vital signs _ _ Refer to respiratory therapist as indicatedDecreased complaints of fatigue and dyspnea on exertion _ _ Gradual increase in cardiorespiratory endurance with wheelchair propulsion, assisted ambulation, and/or therapy sessions _ _ Decreased need for frequent rest breaks due to fatigueImplement a program for home that includes endurance activities and/or breathing techniques as indicated  Spasticity Minimize spasticity in muscles with spasticity management teamTherapeutic strategies _ Refer to physician as indicated, especially if there is a change in spasticity and/or muscle tone and if the patient is prescribed antispasticity medications, recently underwent surgical/medical treatment intervention such as selective dorsal rhizotomy, intrathecalbaclofen pump, or Botox injections _ _ Due to increased tone and spasticity, it is important to incorporate a joint contracture prevention program that includes positioning, stretching, and ROM(1) _ _ Be aware of potentially eliciting spasticity within the involved muscles when performing therapeutic exercises and stretching _ _ Monitor patient\u2019s spasticity and muscle tone and report to referring physicianLoss of spasticity within certain muscle groups may initially reduce a patient\u2019s functional independence with certain activities. Adjust therapeutic exercises as indicated and discuss with physician as neededProvide patient and/or caregivers with home program to manage spasticity as indicated  Incontinence Assist rehabilitation team in bowel/bladder programsFunctional training _ Reinforce established bowel and bladder program as instructed by the medical team _ _ Reinforce the importance of daily skin assessment due to risk of skin breakdown due to incontinence _ Refer to nursing or OT as indicatedN/A Provide patient and/or caregivers with schedule for repositioning and pressure relief. Promote patient and caregiver independence with techniques . Desired Outcomes/Outcome Measures"
        ],
        "indications": [],
        "ICD-9 codes": {},
        "ICD-10 codes": {
            "G37.3": "Acute transverse myelitis in demyelinating disease of central nervous system",
            "A89": "Unspecified viral infection of central nervous system (ICD codes are provided for the reader\u2019s reference and not for billing purposes)"
        },
        "ICD-11": {},
        "G-codes": {},
        "CPT codes": {},
        "HCPCS codes": {},
        "reimbursement": [
            "Reimbursement for therapy will depend on individual insurance contract coverage. There may be state-funded  programs that provide coverage for medical and therapeutic intervention"
        ],
        "presentation signs and symptoms": [
            "Symptoms in children include pain in the neck, back, and lower extremities initially, followed by motor deficits (in about 30% of cases) and sensory loss (in about 10% of cases). Occasionally, there is report of loss of bowel/bladder control, gait disturbances, and visual loss(24)",
            "Onset of loss of motor, sensory, and autonomic function below the level of injury with progressive worsening of signs and symptoms between 4 hours and 21 days after onset. Most common initial symptoms are pain, weakness, sensory loss, and urinary dysfunction(7) \u2013Acute onset: signs and symptoms occur rapidly and are often more severe than those in children who present with subacute onset; commonly associated with back pain(1,24) \u2013Subacute onset: signs and symptoms progress gradually over days to weeks(1)  \u2013The first symptom is often paresthesia ascending from the feet or back pain at the level of myelitis in conjunction with lower extremity paresis and sphincter dysfunction (urinary/fecal incontinence or retention)(4)",
            "Symptoms occur distal to the lesion and are usually bilateral and symmetric but can be asymmetrical or even, in rare situations, unilateral(24) \u2013Lower extremities are typically involved when demyelination occurs in the thoracic region \u2013Upper extremity impairments occur if the lesion is in the cervical-thoracic  region",
            "Localized back or neck pain; may be radicular(8)",
            "Muscle weakness, predominantly in the lower extremities(4) \u2013Flaccidity in the initial phase and then progresses to spastic paraparesis \u2013Two thirds of patients develop paraplegia \u2013Twenty-five  percent develop upper extremity weakness \u2013Five percent develop respiratory muscle weakness",
            "Spontaneous decreased use of hands is possible(24)",
            "Lower extremity sensory impairments such as burning, numbness, tingling, and pricking sensations",
            "Loss of pain, temperature, light touch, position, and vibration sensation,usually located in the thoracic region (80%)(1,4)",
            "Hyperesthesia within 2\u20133 segmental levels",
            "Interscapular pain \u2013Parainfectious TM has a greater tendency to present with back and interscapular pain(1)",
            "Autonomic dysfunction, including paroxysms of hypertension and sweating, urinary retention, and bowel and bladder incontinence \u2013Several studies have demonstrated that urinary dysfunction occurs in 95% of pediatric patients with TM(9)",
            "Fever",
            "Myalgia",
            "Headache(8)",
            "Priapism(7)\u2014i.e., prolonged erection of penis \u2013May not be reported as an initial clinical finding in children \u2013Research suggests that priapism is associated with TM due to an intense and rapid inflammatory process causing functional severing of the cervical spinal cord(7) Causes, Pathogenesis, & Risk Factors"
        ],
        "contraindications precautions to test": [
            "History-taking  and examination procedures may vary depending on the age of the patient, time elapsed since the initial injury occurred, and current circumstances in which the patient is presenting for evaluation; modify as indicated",
            "It is important to respect the patient\u2019s subjective complaints of pain during the physical therapy evaluation and/or treatment sessions. Notify the referring physician if the patient complains of increased pain, joint tenderness upon palpation, and/or the physical therapist (PT) observes increased swelling or decreased ROM",
            "Exam of an infant with TM can be challenging. All the following can be presenting signs in infants:(24) \u2013Lack of spontaneous movement or resistance to examination \u2013Asymmetric movements \u2013Absent response to painful stimuli \u2013Bladder distension or abdominal fullness \u2013Priapism \u2013Refusal to ambulate/bear weight due to pain "
        ],
        "psychometric properties": [],
        "potential complications adverse effects": [],
        "test preparation materials required": [],
        "test procedure": [],
        "test scoring interpretation": []
    },
    "causes & risk factors": {
        "causes": [
            "Incidence: 1\u20138 cases per 1 million persons per year; 1,400 cases per year in the United States(3,4,5,6,8)\u2013Twenty percent of cases are children, or about 300 annually(24)\u2013Two incidence distributions in children: 0\u20132 years and 5\u201317 years(24)",
            "Prevalence: approximately 34,000 in the United States with disabilities due to TM",
            "Idiopathic: 10\u201345%  of all cases of TM,(3) most common cause in children(24)",
            "ATM is often preceded by respiratory illness, vaccination, or systemic illness(24)",
            "TM can present as an isolated disorder or as part of a systemic disease such as:\u2013Multifocal nervous system disease (e.g., multiple sclerosis [MS])(5)\u2013Autoimmune disease (e.g., systemic lupus erythematous [SLE], antiphospholipid syndrome, Sj\u00f6gren\u2019s syndrome,neurosarcoidosis, Beh\u00e7et\u2019s disease, Devic\u2019s syndrome[neuromyelitisoptica], acute disseminated encephalomyelitis)\u2013Postinfectious or postvaccination response causing partial acute disseminated encephalomyelitis(4)-In most cases, symptoms of TM begin after an individual has recovered from the infectious disease and the infectiousagent has not been isolated from the nervous system. Thus, TM appears not to be a direct infectious process, but ratheran autoimmune response triggered by the infectious antigens in genetically susceptible individuals(3,5)-Twenty percent to 40% of TM cases are associated with a preceding viral infection, most often within 1 month of TMonset, although the specific virus rarely is identified-Viruses most commonly implicated are coxsackie A virus (A7, A23), coxsackie B virus, influenza, measles, mumps,rubella, varicella, polio, cytomegalovirus (CMV), mycoplasma, hepatitis C virus, and Epstein-Barr  virus (EBV)(3,5)-Authors of a systematic review of studies between 1970 and 2009 reported 37 cases of TM associated with differentvaccines, including hepatitis B virus, MMR, DPT, and others. Seventy-three  percent of cases developed during the firstmonth post vaccination(3)-Thirteen after hepatitis B, 6 after MMR, 4 after DPT, 4 after rabies, 3 after OPV , 2 after influenza, 1 after typhoid, 1after pertussis, 1 after Japanese B encephalitis, and 2 after multiple vaccines-The connection between the DPT vaccine and onset of TM has not been proven in large case-controlled  studies, andsince 1991 the DTaP, a safer acellular pertussis vaccine, has been in use in the United States(5)-The rarity of post-influenza  vaccination neurological complications reported in recent years makes it impossible toestablish a definite causal relationship between the influenza vaccines and TM(5)",
            "Direct injury to the spinal cord (e.g., radiation, spinal cord infarct, electrical burn)(5,24)",
            "Metabolic deficiencies and mitochondrial disease can cause TM-like symptoms(24)",
            "TM can occur during acute mycoplasma, spirochete, or parasitic infections(24)",
            "A case report described a 15-year-old  female in whom acute myelitis was diagnosed as a result of the Zika virus(32)",
            "A case report described a 17-year-old  female in whom TM was diagnosed as a result of heroin overdose via insufflation(33)"
        ],
        "pathogenesis": [
            "Most likely related to an autoimmune process resulting in an inflammatory response inducing demyelination and neuronalinjury(4,5,24)\u2013Autoantibodies may contribute to the disease process as many patients in whom TM is diagnosed have recently beenimmunized or had a systemic infection\u2013Inflammatory process causes the blood-brain  barrier to break down and CSF pleocytosis occurs within a focal area of thespinal cord(3,5)\u2013Inflammatory markers such as interleukin-6  and other signaling proteins are elevated and levels correlate with diseaseseverity(3)\u2013TM is found to be associated with serologic markers such as collapsing-response  mediator protein 5-IgG  andamphiphysin-IgG,  especially when present as a paraneoplastic syndrome(3)\u2013Presence of anti-SSA/Ro  antibodies in SLE-associated  TM predicts a relapsing course of the disease(3)",
            "Inflammation of the spinal cord may cause partial or complete paralysis along with a posterior column syndrome, anteriorspinothalamic tract syndrome, hemicord syndrome, nonspecific pattern, or complete spinal cord injury (SCI)(1)"
        ],
        "risk factors": [
            "TM diagnosis peaks during the 2nd and 4th decades of life(3,4,7)\u2013Twenty percent of cases occur in individuals younger than 18 years of age(3,7)-Incidence peaks in children younger than 2 years of age (38% of cases) and between 5 and 17 years of age\u2013The female to male ratio is 1:1 in children < 10 years of age but shows female predominance (2.6:1) after 10 years ofage(24)\u2013Etiology of TM in children is mainly post infectious, whereas in adults MS and neuromyelitisoptica together withinfectious/parainfectious etiologies are the most common causes of TM(8)",
            "There is no geographic variation in the incidence of TM(3)",
            "Autoimmune disorders: SLE, Sj\u00f6gren\u2019s syndrome, sarcoidosis, Beh\u00e7et disease, mixed connective tissue disease(1)\u2013Whether there is a direct causal relationship or simply an association between autoimmune and connective tissuedisorders and TM is not known(4)\u2013SLE-One to two percent of individuals with SLE develop TM; SLE most often is diagnosed first, and then they develop TMas a complication of SLE, but TM may occur prior to diagnosis of SLE(3)-Of the small number of patients who develop TM, 42% do so within 5 years of SLE being diagnosed\u2013Sj\u00f6gren\u2019s syndrome-Five percent of individuals with TM have Sj\u00f6gren\u2019s syndrome with CNS involvement and present with cervical cordmyelitis(4)-No retrospective reviews to determine the real incidence or prevalence of TM in primary Sj\u00f6gren\u2019s syndrome(3)",
            "Infectious agents\u2013ATM is most commonly associated with an infection(24)\u2013Viruses: enteroviruses (e.g., echovirus, coxsackie virus, poliovirus, enteric cytopathic human orphan virus),mumps, adenovirus, rubella, measles, human T-lymphotrophic  virus type I, influenza, rabies, herpes simplex,varicella-zoster virus, CMV , HIV , dengue, EBV , West Nile virus(1)-Parainfectious TM tends to manifest with greater muscle weakness and is more likely to result in spinal shock than TMassociated with MS or spinal ischemia(1)\u2013Bacteria: Treponema pallidum , Mycobacterium tuberculosis , Mycoplasma pneumoniae , Bartonella henselae , Histoplasmacapsulatum , Borrelia burgdorferi  (1)-B. burgdorferi  is a spirochete bacterium, found in the deer tick ( Ixodes scapularis ), whose hosts are white-footed miceand deer, with the highest concentrations in the northeast and upper Midwestern United States due to the presence oflarge numbers of their preferred host animals and their proximity to humans. There are other species of genus Borreliaendemic to the western United States, Europe, and Asia(10)-Lyme borreliosis, also known as Lyme disease, is a bacterial infection spread by an infected tick. It is the mostcommon vector-borne  human illness in North America, affecting nearly 15,000 persons annually. See ClinicalReview\u2026Lyme Disease ; CINAHL Topic ID Number: T709229 for more information on this condition-Fifteen percent of persons in whom the condition is not diagnosed and who receive no treatment after the initialinfection will develop acute neuroborreliosis, which can present in a variety of forms, including TM, cerebellarataxia, encephalitis, meningitis, mononeuritis multiplex, cranial neuropathy, and motor or sensory radiculoneuritis-There is limited published research (mainly case reports in children and adults) demonstrating Lyme disease as acontributing factor in TM, with only a small number of patients in these case reports having permanent paraplegia(8)-Tick-borne  infections are more common in spring and early summer(1)-Two cases of ATM as a complication of a silent infection with mycoplasma pneumonia were reported by a hospital inthe United States(27)-Both patients presented with neurological symptoms first and then respiratory symptoms\u2013Spinal cord schistosomiasis",
            "Spinal cord ischemia or injury(1)\u2013Space-occupying  lesions: tumors, herniated nucleus pulposus, spinal abscess, hematoma, spinal stenosis\u2013Vascular: atherosclerosis, thrombosis of spinal arteries, arteriovenous malformations, vasculitis due to intravenous heroinabuse, iatrogenic-There is an inherent increased risk of spinal cord injury or vascular injury resulting in an infarction following anepidural steroid injection or lumbosacral nerve root block. The infarction causes acute paraplegia with sensory, bowel,and bladder dysfunction(1)",
            "Others:\u2013Exposure to radiation(24)\u2013Mild trauma(24)\u2013Obesity(24)"
        ]
    },
    "indications for procedure": [],
    "overall contraindications precautions": [
        "Monitor for signs and symptoms of autonomic dysreflexia in patients with SCI lesions above T6; the clinician should identify and remove precipitating factors if possible and seek emergent medical care. The condition can be life-threatening See Clinical Review\u2026Autonomic Dysreflexia in Adults ; CINAHL Topic ID Number: T708491 for more information on this condition Signs of autonomic dysreflexia include the following:(28) \u2013Elevated blood pressure  \u2013Pounding headache \u2013Bradycardia \u2013Profuse sweating \u2013Piloerection (goose bumps), usually above the level of the lesion but sometimes below \u2013Increased spasticity \u2013Restlessness \u2013Vasoconstriction below level of lesion and vasodilation above level of lesion \u2013Constricted pupils \u2013Nasal congestion \u2013Blurred vision",
        "Orthostatic hypotension is a common occurrence in individuals with SCI or TM. Monitor for signs and symptoms when performing transfers, especially in the acute care and rehabilitation phases",
        "Fractures have been noted to occur during mobility in patients with longstanding SCI; these may be related to decreased bone mineral density(1)",
        "All individuals who have TM experience some degree of bladder dysfunction. Catheterization places patients at risk for developing urinary tract infections or false passages in the urethra, making further catheterization difficult, with possible stricture development. Be aware of signs and symptoms such as fever and irritability(1,2)",
        "Patients are at an increased risk for developing deep venous thrombosis (DVT) and pulmonary embolism. If the patient has developed DVT, withhold physical therapy for 48 to 72 hours; obtain orders from physician prior to resuming exercise and mobilization",
        "Pressure ulceration of the skin can occur if pressure relief is not performed at regular intervals as well as if there is not compliance with proper bowel and bladder management program. Skin will macerate and break down around the sacral region(1)",
        "Patients with TM may require mechanical ventilator assistance depending on the degree of respiratory muscle weakness. These patients are at risk for developing respiratory infections, pneumonia, and sleep apnea. Risk can be compounded by any prescribed sedating medications or respiratory-depressing narcotics(1)",
        "Heterotopic ossification (HO) may develop in the soft tissue of the thigh or upper arm, significantly limiting ROM and contributing to joint stiffness.(1) If HO is suspected, contact physician immediately See Clinical Review\u2026Heterotopic Ossification ; CINAHL Topic ID Number: 708507 for more information on this condition",
        "Gastrointestinal complications may develop with an acute ileus and subsequent chronic constipation(1)",
        "See specific  Contraindications/precautions to examination   and  Contraindications/precautions   under Assessment/"
    ],
    "contraindications precautions to procedure": {},
    "guidelines for use of procedure": {},
    "examination": {
        "contraindications precautions to examination": [
            "History-taking  and examination procedures may vary depending on the age of the patient, time elapsed since the initial injury occurred, and current circumstances in which the patient is presenting for evaluation; modify as indicated",
            "It is important to respect the patient\u2019s subjective complaints of pain during the physical therapy evaluation and/or treatment sessions. Notify the referring physician if the patient complains of increased pain, joint tenderness upon palpation, and/or the physical therapist (PT) observes increased swelling or decreased ROM",
            "Exam of an infant with TM can be challenging. All the following can be presenting signs in infants:(24) \u2013Lack of spontaneous movement or resistance to examination \u2013Asymmetric movements \u2013Absent response to painful stimuli \u2013Bladder distension or abdominal fullness \u2013Priapism \u2013Refusal to ambulate/bear weight due to pain "
        ],
        "history": {
            "history of present illness": {
                "mechanism of injury or etiology of illness": " Mechanism of injury or etiology of illness -When did the patient first notice any signs/symptoms of motor, sensory, or autonomic impairment? -Has the patient recently been ill? Fever? Rash? Cough? -Any recent vaccinations? -Any recent travel out of the country? -Any recent surgeries requiring an epidural? -Has the patient been exposed to pets? -Has the patient been bitten by an animal or tick? Has the patient recently traveled? If so, where and when? -When was TM diagnosed? -In a retrospective cohort study of 47 children, authors associated shorter time to accurate diagnosis of TM with better outcome(11) -In a retrospective survey of 20 children with TM based on parent reports, when a neurologist made the initial diagnosis it was incorrect (not TM) in 70% of cases and when a primary care physician, ER physician, or other physician made the initial diagnosis it was incorrect in 100% of cases(12) -What is the sensory and motor level of the lesion? -Who makes up the patient\u2019s medical team? -Any history of complications associated with TM?",
                "course of treatment": {
                    "medical management": "What medical treatment intervention has occurred? If patient was hospitalized, where and for how long? Has the patient received physical and/or occupational therapy in the past? Has the patient been educated on self-catheterization  for urinary incontinence? Does the patient require mechanical ventilation assistance? Hospitalization is often necessary to monitor vital signs, manage respiratory status, and manage bladder or bowel complications in the acute phase(1,4) Symptomatic treatment must be started early with the appropriate medications and rehabilitation services(4) Bowel and bladder programs should begin immediately to reduce the risk of stool obstruction or kidney damage because of the neurogenic bowel or bladder condition. An indwelling catheter may be used initially for bladder drainage, but intermittent catheterization is commonly instituted whenever possible(1)",
                    "surgical management": [],
                    "medications": "Determine what medications clinician has prescribed; are they being taken? High-dose  intravenous or oral corticosteroids are the standard first-line  intervention for treatment of TM to prevent further damage to the spinal cord as a result of the underlying inflammatory process; evidencebased  research is still limited and based mainly on case studies(1,4,11,13) Cyclophosphamide in combination with methylprednisolone has some success in patients with SLE-related  TM(10)oral/intrathecalbaclofen, tizanidine, 4-aminopyridine(4)gabapentin, carbamazepine, phenytoin, amitriptyline, baclofen (oral/intrathecal)(4) Opioids often have little benefit for TM patients with neuropathic pain(7)anticholinergics(4) DVT prophylaxis and anticoagulant treatment(1) Plasma exchange may be indicated in patients with evidence of severe demyelination(4)",
                    "diagnostic tests completed": [
                        "Diagnostic tests completed: Typical diagnostic tests for patients with myelopathy include MRI with or without IV contrast and CT scan with or without IV contrast(25). Lumbar puncture for CSF analysis may be indicated to rule out CNS infections(4,24)"
                    ],
                    "alternative therapies": "Document any use of home remedies (e.g., ice or heating pack) or alternative therapies (e.g., acupuncture) and whether they changed the symptoms",
                    "previous therapy": "Document whether patient has had occupational or physical therapy for this or other conditions and what specific treatments affected symptoms "
                },
                "aggravating easing factors": " Aggravating/easing factors  (and length of time each item is performed before the symptoms come on or are eased)",
                "body chart": "Use body chart to document location and nature of symptoms -Shoulder pain may develop due to increased upper extremity use for functional mobility such as transfers and wheelchair propulsionWheelchair User ; CINAHL Topic ID Number",
                "nature of symptoms": "Document nature of symptoms (e.g., constant vs intermittent, sharp, dull, aching, burning, numbness, tingling). Patient may experience neurogenic pain as well as mechanical, referred, or radicular pain depending on the cause -Chronic sensory impairments have been reported in 46% of children with TM(11)",
                "rating of symptoms": "Use a visual analog scale (V AS) or 010  scale to assess symptoms at their best, at their worst, and at the moment (specifically address if pain is present now and how much) -The Oucher Pain Scale is a V AS for the pediatric population -FLACC pain scale for children 2 months to 7 years of age or for nonverbal patients",
                "pattern of symptoms": "Document changes in symptoms throughout the day and night, if any; also document changes in symptoms due to weather or other external variables",
                "sleep disturbance": "Document number of wakings/night",
                "other symptoms": "Document other symptoms patient may be experiencing that could exacerbate the condition and/or symptoms that could be indicative of a need to refer to physician (e.g., dizziness, bowel/bladder/sexual dysfunction, difficulty breathing, saddle anesthesia, vision changes, nausea). Does the patient report depression or demonstrate signs and symptoms of depression?(1)",
                "respiratory status": "Does the patient require supplemental oxygen? If so, document amount and frequency Barriers to learning -Are there any barriers to learning? Yes__ No__ -If Yes, describe ________________________"
            },
            "medical history": {
                "past medical history": {
                    "previous history of same similar diagnosis": " Previous history of same/similar diagnosis What surgical procedures has the patient undergone, if any? Document the presence of any allergies If an autoimmune disease or connective tissue disorder has been diagnosed in the patient, when? What has been the medical management for this condition?",
                    "comorbid diagnoses": "Ask patient about other problems, including diabetes, cancer, heart disease, neurologic deficits, autoimmune disorders, psychiatric disorders, and orthopedic disorders",
                    "medications previously prescribed": "Obtain a comprehensive list of medications prescribed and/or being taken (including OTC drugs). Is there is a history of substance abuse? Smoking?",
                    "other symptoms": "Ask patient about other symptoms he or she may be experiencing"
                }
            },
            "social and occupational history": {
                "patient\u0432\u0402\u2122s goals": "",
                "vocation avocation and associated repetitive behaviors, if any": "Does the patient attend school? If so, traditional or home school? Does the patient work inside/outside of the home? Are there any barriers to learning or accessing his or her school environment? Does the patient want to return to the work environment? Does the patient drive? Does the patient participate in recreational or competitive sports? Is the patient involved in sports, leisure activities, and/or community programs?",
                "functional limitations assistance with ADLs adaptive equipment": "What ADLs can the patient perform independently, with or without adaptive equipment? Which assistive devices/adaptive devices does the patient currently use?",
                "living environment": "Stairs, number of floors in home, with whom patient lives (e.g., caregivers, family members). Identify if there are any barriers to independence in the home; any modifications necessary, such as widening doorways for a wheelchair, ramp to access home or car? Any barriers at school?"
            }
        },
        "relevant tests and measures": {
            "general": " \u203aRelevant tests and measures",
            "anthropometric characteristics": " Anthropometric characteristics \u2013Document patient\u2019s height and weight for wheelchair prescription and other assistive devices that may be needed. Document BMI",
            "assistive and adaptive devices": " Assistive and adaptive devices \u2013Document which assistive and adaptive devices the patient and/or caregivers are currently using. Are they appropriate? Are additional devices indicated, such as pressure-relieving seating systems and/or mattresses?",
            "balance": " Balance \u2013Evaluate patient\u2019s sitting and standing static and dynamic balance as indicated. Note degree of assistance \u2013Pediatric Balance Scale (PBS)",
            "cardiorespiratory function and endurance": [
                "Document vital signs at rest and during mobility",
                "Lack of or impairment of sympathetic innervation to the heart (which normally originates from T1T4)  may dramatically alter cardiac output, maximal heart rate, and regional blood flow",
                "Assess which respiratory muscles (primary and accessory) are impaired(14) -Patients with SCIs above C4 require ventilator support for respiration -Monitor for signs and symptoms of atelectasis or infection (e.g., fever, change in respiratory rate, dyspnea, tachycardia, anxiety, increased volume, or change in consistency of secretions) -Document ability to cough and need for support during coughing. Forceful expiration and cough may be affected depending on the level of the spinal cord lesion",
                "May use Dyspnea Scale to monitor level of exertion(13)"
            ],
            "circulation": "Check bilateral pulses. Be aware of signs and symptoms of DVTCranial nerves should not be affected(1) Functional mobility  (including transfers, etc.) \u2013Use WeeFIM for objective, functional measurements \u2013Complete a functional assessment, including bed mobility and transfers to/from toilet/commode, wheelchair, bed, car, chair/couch using necessary assistive/adaptive equipment \u2013Depending on the patient\u2019s age, assess ability to perform age-appropriate  gross motor skills \u2013Evaluate wheelchair mobility and skills(15,16) -The SmartWheel(15,16) -An assessment device that can be attached to the majority of standard wheelchairs that records the amount of force put forth with every push, length and ease of every push, and push frequency -Data collected may be utilized as objective outcome data or for reimbursement -The SmartWheel Users\u2019 Group (SWUG) created a standard clinical protocol for the SmartWheel with which the clinician evaluates each patient(15,16) -Propelling a wheelchair over smooth tile -Propelling a wheelchair over carpet -Propelling a wheelchair up a ramp that conforms to the specifications of the Americans with Disabilities Act -Performing a figure 8 on smooth tile -Average peak resultant force, velocity, push frequency, and stroke length -The SWUG felt that each patient should complete a wheelchair velocity assessment first; minimum velocity for safe community propulsion must be attained (reportedly 1.06 m/s)(15) -Plot out a 10-m  path and record type of surface -Patient begins at first line and propels over finish line -Clinician counts number of pushes required to cross line -Velocity (m/s) = 10 m divided by time to complete 10 m (in seconds) -Push frequency (contacts per second) = number of pushes in 10 m divided by time to complete 10 m (in seconds)",
            "functional mobility": "",
            "gait locomotion": "Evaluate gait as indicated and appropriate, depending on the level of impairment (4)  \u2013The Walking Index for Spinal Cord Injury (WISCI) may be more comprehensive and more responsive in the measurement of ambulatory recovery than other walking scales for patients with SCI. The WISCI II is an amended version with an ordinal scale(17,18) -Zero indicates a nonambulatory status; 20 indicates an individual can ambulate at least 10 m without physical assist or assistive device \u2013The Hauser Ambulation Index may be useful; it is a rating scale from 0 to 9 that assesses time to walk 25 feet and level of assistance required, 0 being normal ambulation and 9 being unable to transfer and needs assistance of a wheelchair(26) \u2013A cross-sectional  study evaluated three timed walking tests in individuals with SCI and reported the instruments were valid and reliable outcome measures in this population. These tests were the Timed Up & Go (TUG) test, the 10-meter walk test, and the 6-minute  walk for distance test (6MWT)(18) -Correlation among the results of these three tests was good compared to the WISCI II, except for the circumstance in which walking function was poor. Scores on the TUG test and the 10-meter  walk test reliability decreased in this circumstanceAssess bilateral upper and lower extremity joint mobility. Note if there is hypomobility associated with increased tone or spasticity (4) Motor function (motor control/tone/learning) \u2013Assess bilateral upper and lower extremities for the presence of spasticity and tone. Spasticity is usually symmetrical, affecting the legs more than the arms. Use the Modified Ashworth Scale for Spasticity \u2013Severe TM may be associated with hypotonia in the acute phase during spinal shock but typically develops into hypertonia and spasticity -Patient Reported Impact of Spasticity Measure (PRISM)(19) -Seven subscales -Validity and reliability of this test have been demonstrated in 180 individuals with SCI tested at 5 different locations \u2013The author of a literature review reported that the evaluation of spasticity in patients with SCI might best be completed by administering multiple tools in order to obtain the most accurate clinical picture, since various tests assess distinctive features of spasticity. However, many of these tests require validity and reliability studies to further support their use in -Ashworth Scale and Modified Ashworth Scale -Penn Spasm Frequency Scale -Spinal Cord Assessment Tool for Spasticity -Visual Analogue Scale self-related  scale of spasticity -Wartenberg Pendulum Test \u2013Isolated motor control assessment is often appropriate when there is lack of coordinated movement or abnormal tone or the patient cannot comply with manual muscle testing (MMT)",
            "muscle strength": "Assess bilateral upper and lower extremity muscle strength and trunk/abdominal strength per MMT. Document thoroughly. MMT may be used to monitor patient\u2019s recovery status. MMT is not an optimal means of measuring isolated muscle strength in patients with abnormal tone. In cases in which MMT is not appropriate, assess the patient\u2019s ability to elicit specific muscle groups in gravity-eliminated  or anti-gravity  positions. See Special tests specific to diagnosis , below",
            "observation inspection palpation including skin assessment": [
                "Thorough assessment of skin integrity, especially over bony prominences, noting the presence of irritation, redness, or breakdown",
                "If wound is present, note location, size, color, depth, and exudate",
                "Palpate soft tissue for any abnormal findings"
            ],
            "posture": "Complete sitting postural assessment, especially in wheelchair, if already prescribed. Note any asymmetry, including scoliosis and leg-length  discrepancy (4)",
            "range of motion": "Assess upper and lower extremity active ROM (AROM) and passive ROM (PROM). Patient may have contractures (4)",
            "self-care activities of daily living": "",
            "reflex testing": "Assess bilateral deep tendon reflexes. May have hyperreflexia or areflexia. Assess for Babinski reflex. Depending on the patient's age or clinical presentation, developmental reflex testing may be indicated Self-care/activities  of daily living  (objective testing)  \u2013Evaluate ADLs(1) -Patients with C1\u2013C4  lesions are usually dependent for ADLs -Patients with C5\u2013C7  lesions may be able to feed and dress themselves with adaptive equipment and setup -Patients with C8\u2013S1  lesions have the ability to be independent with self-care  using adaptive equipment, with lower levels having the most independence \u2013May use the Pediatric Evaluation of Disability Index (PEDI) to assess functional ability of children ages 6 months to 7 years in 3 categories (self-care,  mobility, and social function) Sensory testing  (1) \u2013Assess bilateral upper and lower extremities and trunk for pinprick, light touch, sharp-dull,  discrimination, temperature, and vibration. Note level of impairment and any asymmetry \u2013Assess bilateral upper and lower extremities for joint position and note any asymmetry \u2013Refer to the physician\u2019s report regarding anal/perianal sensation",
            "sensory testing": "",
            "special tests specific to diagnosis": " Special tests specific to diagnosis \u2013American Spinal Injury Association (ASIA) Impairment Scale(20) -Illustrates the extent of sensory and motor function that remains intact below the level of the lesion -Grade A\u2013E severity scale; A is complete lesion, B\u2013D describes incomplete lesions, and E is normal \u2013Needs Assessment Checklist (NAC)(21) -Created for patients with SCIADLs, bladder management, bowel management, skin management, mobility, community, wheelchair and equipment, psychosocial issues, and discharge coordination -4-point  rating scale; 0 denotes dependence and 3 independence -Reported as having high internal consistency, item validity, test-retest  reliability, and good concurrent validity -May be useful in therapeutic goal planning \u2013Spinal Cord Independence Measure (SCIM)(22)mobility, self-management,  and respiration and sphincter management -Ranges from 0 to 40 points -Amended versions include SCIM II and III",
            "speech and language examination": "",
            "neurological examination": "",
            "oral structure and oral motor function": "",
            "perception": "",
            "arousal attention cognition": " Arousal, attention, cognition (including memory, problem solving)  \u2013Assess if the patient is alert and oriented x 4 \u2013Note affect, monitor for signs of depression or anxiety. Patients with TM are at increased risk for depression, and patient and/or caregiver psychological support should be made available in both the acute phase and the long-term phase as needed(12)",
            "aac assessment": "",
            "swallow examination": "",
            "tracheostomy examination": ""
        }
    },
    "assessment plan of care": {
        "contraindications precautions": {
            "cryotherapy contraindications": [],
            "cryotherapy precautions": [],
            "contraindications precautions": [
                "Decreased circulation",
                "Decreased sensation",
                "Acute/subacute traumatic and inflammatory conditions",
                "Skin infections",
                "Impaired cognition or language barrier",
                "Malignant tumors",
                "Tendency for hemorrhage or edema",
                "Heat rubs",
                "Stimulation through or across the chest ",
                "Cardiac pacemakers",
                "Implanted stimulators",
                "Over carotid sinuses",
                "Uncontrolled hypertension/hypotension",
                "Peripheral vascular disease",
                "Thrombophlebitis",
                "Pregnancy",
                "Over pharyngeal area",
                "Diminished sensation",
                "Acute inflammation",
                "Seizure history",
                "Confused patients",
                "Immature patients",
                "Obesity",
                "Osteoporosis",
                "Cancer",
                "Used in close proximity to diathermy treatment"
            ],
            "superficial heat is contraindicated with": [],
            "electrotherapy contraindications precautions include": [],
            "other": [
                "Clinicians should follow the guidelines of their clinic/hospital and what the patient\u2019s physician orders. The summary below is meant to serve as a guide, not to replace orders from a physician or a clinic\u2019s specific protocols",
                "Only those contraindications/precautions applicable to this diagnosis are mentioned below, including with regard to modalities. Rehabilitation professionals should always use their professional judgment",
                "Patients with TM are at risk for falls; follow facility protocols for fall prevention and post fall-prevention instructions at bedside, if inpatient. Ensure that patient and family/caregivers are aware of the potential for falls and educated about fall-prevention  strategies. Discharge criteria should include independence with fall-prevention strategies",
                "Thermotherapy  contraindications(23)",
                "Electrotherapy  contraindications/precautions (in some cases, when approved by the treating physician , electrotherapy may be used under some of the circumstances listed below when benefits outweigh the perceived risk)(23)"
            ]
        },
        "diagnosis need for treatment": "Early diagnosis and treatment intervention are essential for improving the patient\u2019s",
        "rule out": " Rule out  (24) Infectious myelitis Congenital malformations (neurenteric cysts, spinal cord tethering)(31) Vascular disorders (cavernoma, Cobb syndrome, spinal cord infarction, arteriovenous malformation)(31) Toxic injury relating to chemotherapy and/or radiation(31) Postradiation myelopathy Compressive myelopathy\u2014due to trauma, arteriovenous malformation, discitis, epidural abscess vertebral osteomyelitis, tumor Ischemic myelopathy\u2014due to spinal cord infarct, angiitis/vasculitis, fibrocartilaginous embolism Autoimmune\u2014due to acquired demyelination syndromes, systemic autoimmune disease, and paraneoplastic syndrome Chiari I malformation (CMI) \u2013Authors of a retrospective study conducted in the United States suggest a high prevalence rate of CMI in patients with TM(34)",
        "prognosis": [
            "The use of a multidisciplinary healthcare team is the best approach when evaluating and treating individuals with TM to facilitate collaboration among medical professionals",
            "Once the patient is medically stable, the PT\u2019s role is critical in maximizing the patient\u2019s functional independence as well as educating the patient and caregivers on how to safely return to his/her home and community with this life-altering condition(3,12) \u203aPrognosis",
            "There is complete recovery in 33\u201350%  of children. However, up to 20% of children have significant residual disability (not ambulatory, severe sensory loss, no sphincter control)(24)",
            "Researchers in France and the United Kingdom determined that female sex and the presence of associated brain lesions were risk factors for relapse(29) \u2013A study of 95 children with ATM of whom 16 relapsed with diagnosis of either MS or neuromyelitisoptica \u2013The researchers also looked at outcome and determined that female sex, severe impairment at onset per ASIA scale, gadolinium enhancement on spinal MRI, absence of pleocytosis, and absence of cervical or cervico-thoracic lesion on spinal MRI were predictive of poor outcome",
            "Acute partial TM and brain MRI abnormalities at initial presentation are significant predictors of a subsequent diagnosis of MS in children with ATM(30) \u2013Based on a retrospective study conducted in France of 30 children < 16 years of age with median age of onset of 11 years of age. At an average of 4 years later, 5 (17%) had developed MS ",
            "Prognosis for recovery is variable and is often related to clinical presentation. Recovery often takes months and may or may not be complete(1,8)",
            "Recovery of motor function, if it occurs, usually begins within 8 weeks and can continue for up to 2 years(9)",
            "If no recovery has occurred by 1 to 3 months, complete recovery is less likely(1)",
            "Fifty to seventy percent of patients with TM have partial or complete recovery and are able to be ambulatory with or without assistive devices(13)",
            "One third of patients recover fully in 3 to 6 months, one third of patients have partial recovery with a moderate degree of residual symptoms and disability, and one third have very little improvement, with severe residual disabilities, or die(1,3,4,24) \u2013Residual neurologic deficits include motor weakness, sensory impairments, and autonomic dysfunction(24) \u2013Sphincter dysfunction improves more slowly than motor and sensory impairments(24)",
            "There is inconsistency in the published literature regarding the patient\u2019s prognosis based on acute vs subacute progression of symptoms \u2013The authors of a retrospective study involving 47 children with TM suggested that the rapidity of initial symptom progression did not predict a worse long-term outcome(11) \u2013Subacute or gradual progression of sensory and/or motor symptoms over days and weeks indicated a better long-term prognosis",
            "In the same retrospective study, authors concluded that children may present with more severe long-term  clinical impairments than adults(11) \u2013Eighty-nine  percent of the pediatric patients were bed or wheelchair dependent or required ventilation assistance, whereas the majority of adults presented with only mild residual impairments \u2013Onset before the age of 3 years is associated with more severe long-term  disability than onset at ages 5\u201317 years(7)",
            "Patients more likely to have a poor prognosis present with: \u2013acute progression of sensory and/or motor symptoms over hours, spinal shock, severe neurological dysfunction, sensory impairments at cervical levels, incontinence, CSF positive 14-3-3  protein, and lack of recovery after 3 months(3,4)",
            "Patients more likely to have a good prognosis present with: \u2013subacute progression of sensory and/or motor symptoms over days or weeks, no abnormal posterior spinal cord column functions, and normal deep tendon reflexes(4)",
            "Functional limitations depend on the level of the injury and muscles that are still innervated(1) \u2013Individuals with C4 innervation: dependent for most self-care activities, although environmental control can be achieved by sip-and-puff,  head, cheek, or tongue switches or by infrared or voice-activated  devices \u2013Individuals with C5 innervation: independent self-feeding  and grooming with equipment, independent use of a power wheelchair, and possibly driving of a specifically adapted van \u2013Individuals with C6 innervation: independent with upper extremity dressing, bathing, with equipment, use of a sliding board, and self-catheterization  with appropriate aids \u2013Individuals with C7 innervation: potentially independent in all self-care  activities with equipment, and the patient may be able to live alone \u2013Individuals with T1 innervation: independent use of a manual wheelchair and self-catheterization  in most cases -Upper thoracic innervation allows for easier use of a manual wheelchair and independence with bladder and bowel self-care -Some ambulation with knee-ankle-foot  orthoses may be attempted for exercise, but independent bipedal ambulation is not realistic unless the patient has some upper lumbar innervation \u2013Each additional lumbar and sacral innervation level increases the ease of ambulation \u2013Patients with incomplete SCI will present with different combinations of functional abilities",
            "Chronic bladder dysfunction is the most common long-term  neurological impairment(8,11) \u2013In a retrospective analysis covering the years 1995\u20132004,  14 children in the United States with TM were evaluated to determine if there was a correlation between motor and bladder recovery following disease onset(2) -Thirty-five  percent had clinical cervical sensory impairments and 65% had thoracic sensory impairments -Full motor recovery was defined as walking without assistance. Partial recovery was walking with an assistive device or support. No motor recovery was defined as being wheelchair dependent  -Full bladder recovery was defined as normal micturition with continence and without medication. Partial recovery was the ability to void voluntarily but requiring anticholinergic medications to control urinary incontinence. No motor recovery was defined as the inability to void voluntarily, necessitating intermittent catheterization with or without anticholinergic medications -During the acute phase, all patients experienced lower extremity motor deficits and bladder dysfunction, with 5/14 experiencing motor loss prior to bladder dysfunction and 9/14 experiencing bladder and motor dysfunction occurring at the same time -Motor recovery -Twenty-eight  percent full recovery -Forty-two  percent partial recovery -Twenty-eight  percent no recovery -Bladder recovery -Twenty-eight  percent full recovery -Fourteen percent partial recovery -Fifty-seven  percent no recovery -Full motor recovery was associated with full bladder recovery and no motor recovery was associated with no bladder recovery -Partial motor recovery was associated with no bladder recovery or partial bladder recovery -No significant bladder recovery was seen beyond 4 months in this study \u203aReferral to other disciplines  (as indicated)",
            "Physiatrist",
            "Psychiatrist and/or neuropsychologist \u2013Mood and anxiety disorders are among the most common long-term  consequences of TM. Psychological state of the patient and caregivers is very important and there should be ongoing monitoring for depression(1,13)",
            "Respiratory therapist",
            "Social worker and/or counselor/therapist to assist with community resources and patient-family  care support \u2013Coordinates discharge planning and community reintegration(10)",
            "Occupational therapist (OT) for difficulties with ADLs",
            "Speech-language  pathologist (SLP) if there are signs, symptoms, or risk of dysphagia",
            "Gastroenterologist",
            "Urologist",
            "Recreational therapist",
            "Wound care specialist",
            "Orthotist",
            "Chronic pain management team(11)",
            "In a 2008 survey given to parents of 20 children with TM, 90% of the parents expressed a desire to consult with a psychiatrist, but only 25% were successful in making a visit. Seventy percent desired a consult with a gastroenterologist, but only 25% were successful in scheduling a visit \u2013Psychiatry was the most sought-after  discipline following the acute care phase, indicating a strong need for mental health assistance \u2013One of the most common reported symptoms is depression"
        ],
        "referral to other disciplines": "",
        "other considerations": [
            "Nursing in conjunction with the physician should implement a bowel and bladder program \u2013This includes adequate fluids, proper diet, activity, and scheduled bowel movements as necessary for those with residual bowel dysfunction \u2013This may also include stool softeners, osmotic/stimulant/bulk laxatives, and digital stimulation \u2013Bowel training is often started daily in the hospital, but can be extended to every 2 or 3 days once the patient returns home(1)"
        ],
        "treatment summary": [
            "In general, physical therapy treatment intervention consists of:(10) \u2013maximizing muscle strength \u2013increasing and maintaining ROM in order to prevent joint contractures \u2013maximizing functional, independent mobility and ADLs \u2013gait training and/or wheelchair mobility \u2013improving cardiovascular and respiratory endurance and respiratory \u2013pain management using modalities \u2013assessment for necessary assistive and adaptive devices \u2013patient and primary caregiver education . Problem Goal Intervention Expected Progression Home Program Pain Decrease patient\u2019s subjective complaints of painTherapeutic strategies _ Refer to physician as indicated _ _ Implement joint contracture prevention and management strategies _ _ Refer to physician as indicated _ _ Physical agents and mechanical modalities _ May try thermal therapy or electrotherapeutic interventions to manage pain as indicated and appropriateN/A Instruct patient and/ or caregivers in pain management for home Risk of DVT Minimize risk of DVT Prescription, application of devices and equipment _ Mobility, ROM, and compression stockings are some examples of strategies to reduce the risk of DVTInstruct patient and/or caregivers in techniques to reduce the risk of DVT  Pressure sores _ _ Decreased sensationPrevent pressure sores from developing _ _ Assist with healing existing sores _ _ Implement strategies to compensate for sensory lossWound care/"
        ]
    },
    "desired outcomes outcome measures": {
        "management of pressure sores": [],
        "independent with bowel and or bladder management": [],
        "decreased complaints of pain": [
            "V AS and Oucher pain scale",
            "Wheelchair User\u2019s Shoulder Pain Index"
        ],
        "patient and or caregiver education regarding tm and the long-term  management of the disease": [
            "NAC, SCIM, ASIA impairment scale"
        ],
        "maximize and improve rom": [
            "Goniometry"
        ],
        "maximize and improve strength": [
            "MMT or measures of functional strength"
        ],
        "maximize independence with adls": [
            "TUG test"
        ],
        "maximize independence with functional mobility  wheelchair and or gait": [
            "WISCI, WISCI I, or WISCI II",
            "WeeFIM, PEDI, TUG"
        ],
        "maximize endurance": [
            "10-meter  walk test, 6MWT"
        ],
        "maximize and improve sitting and standing balance": [
            "PBS and Berg Balance Scale"
        ],
        "spasticity management": [
            "PRISM, Modified Ashworth Scale"
        ],
        "prevention of joint contractures": []
    },
    "maintenance or prevention": [
        "Pain or dysesthesia is usually the most debilitating symptom of TM",
        "Long-term  issues that may need to be monitored on a regular basis are skin integrity, hygiene, nutrition, pain, arthritis, constipation, urinary incontinence, and spasticity(11)",
        "Routine follow-up  for renal ultrasound and urodynamic evaluations to monitor bladder dysfunction(1)",
        "Intramuscular botulinum toxin injections or alcohol and phenol nerve or motor point blocks may be needed to reduce spasticity, decrease pain, and improve functional mobility(1)",
        "An intrathecalbaclofen pump may be needed to reduce moderate to severe spasticity(1) ",
        "Diaphragmatic electrodes (phrenic nerve stimulation) implantation when respiratory muscles are affected(1)"
    ],
    "patient education": [
        "Transverse Myelitis Association website, https://wearesrna.org/",
        "The Transverse Myelitis Center, Johns Hopkins Medicine website, https://www.hopkinsmedicine.org/ neurology_neurosurgery/centers_clinics/transverse_myelitis/ Coding Matrix References are rated using the following codes, listed in order of strength: MPublished meta-analysis SRPublished systematic or integrative literature review RCTPublished research (randomized controlled trial) RPublished research (not randomized controlled trial) CCase histories, case studies GPublished guidelinesRVPublished review of the literature RUPublished research utilization report QIPublished quality improvement report LLegislation PGRPublished government report PFRPublished funded reportPPPolicies, procedures, protocols XPractice exemplars, stories, opinions GIGeneral or background information/texts/reports UUnpublished research, reviews, poster presentations or other such materials CPConference proceedings, abstracts, presentation"
    ],
    "references": [
        {
            "number in article": 1,
            "reference": "Lim PAC. Transverse myelitis. In: Frontera WR, Silver JK, Rizzo TD Jr, eds. Essentials of Physical Medicine and Rehabilitation . 4th ed. Philadelphia, PA: Saunders; 2019:952-959.  (GI)"
        },
        {
            "number in article": 2,
            "reference": "DaJusta DG, Wosnitzer MS, Barone JG. Persistent motor deficits predict long-term  bladder dysfunction in children following acute transverse myelitis. J Urol. 2008;180(4):1174-77.  (R)"
        },
        {
            "number in article": 3,
            "reference": "Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmune Rev . 2010;9(5):395-99.  (RV)"
        },
        {
            "number in article": 4,
            "reference": "Hariharan AR, Choi JH, Cook RW, et al. Orthopaedic manifestations of transverse myelitis in children. J Pediatr Orthop . 2021. doi:https://doi.org/10.1097/ BPO.0000000000001845. (R)"
        },
        {
            "number in article": 5,
            "reference": "Agmon-Levin  N, Kivity S, Szyper-Kravitz  M, Shoenfeld Y. Transverse myelitis and vaccine: a multi-analysis.  Lupus. 2009;18(13):1198-204.  (SR)"
        },
        {
            "number in article": 6,
            "reference": "Alper G, Petropoulou KA, Fitz CR, Kim Y. Idiopathic acute transverse myelitis in children: an analysis and discussion of MRI findings. Mult Scler . 2011;17(1):74-80.  (R)"
        },
        {
            "number in article": 7,
            "reference": "Hammond ER, Kerr DA. Priapism in infantile transverse myelitis. Arch Neurol . 2009;66(7):894-97.  (C)"
        },
        {
            "number in article": 8,
            "reference": "Bigi S, Aebi C, Nauer C, Bigler S, Steinlin M. Acute transverse meylitis in Lyme neuroborreliosis. Infection. 2010;38(5):413-16.  (C)"
        },
        {
            "number in article": 9,
            "reference": "Tanaka ST, Stone AR, Kurzrock EA. Transverse myelitis in children: long-term  urological outcomes. J Urol. 2006;175(5):1865-68.  (R)"
        },
        {
            "number in article": 10,
            "reference": "Oleson CV, Sivalingam JJ, O'Neill BJ, Staas WE, Jr. Transverse myelitis secondary to coexistent Lyme disease and babesiosis. J Spinal Cord Med . 2003;26(2):168-71.  (C)"
        },
        {
            "number in article": 11,
            "reference": "Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood. Neurology . 2007;68(18):1474-80.  (R)"
        },
        {
            "number in article": 12,
            "reference": "Trecker CC, Kozubal DE, Quigg M, et al. Quality care in transverse myelitis: a responsive protocol. J Child Neurol . 2009;24(5):577-83.  doi:10.1177/o883073808325655. (R)"
        },
        {
            "number in article": 13,
            "reference": "Frohman EM, Wingerchuk DM. Transverse myelitis. N Engl J Med . 2010;363(6):564-72.  (RV)"
        },
        {
            "number in article": 14,
            "reference": "Atrice M, Ackerman PM, Webber K, Pharo E, Sasso-Lance  E, Hammad R. Traumatic spinal cord injury. In: Umphred DA, Burton GU, Lazaro RT, Roller ML, eds. Neurological Rehabilitation . 7th ed. St. Louis, MO: Mosby Elsevier; 2020:393-454.  (GI)"
        },
        {
            "number in article": 15,
            "reference": "Cowan RE, Boninger ML, Sawatzky BJ, Mazoyer BD, Cooper RA. Preliminary outcomes of the SmartWheel Users' Group database: a proposed framework for clinicians to objectively evaluate manual wheelchair propulsion. Arch Phys Med Rehabil . 2008;89(2):260-268.  doi:10.1016/j.apmr.2007.08.141. (R)"
        },
        {
            "number in article": 16,
            "reference": "The SmartWheel. Out-Front  Web site. http://www.out-front.com/smartwheel_overview.php . (R)"
        },
        {
            "number in article": 17,
            "reference": "van Hedel HJ, Wirz M, Dietz V. Assessing walking ability in subjects with spinal cord injury: validity and reliability of 3 walking tests. Arch Phys Med Rehabil . 2005;86(2):190-196.  (R)"
        },
        {
            "number in article": 18,
            "reference": "Cook KF, Teal CR, Engebretson JC. Development and validation of Patient Reported Impact of Spasticity Measure (PRISM). J Rehabil Res Dev . 2007;44(3):363-371.  (R)"
        },
        {
            "number in article": 19,
            "reference": "Hsieh JT, Wolfe DL, Miller WC, et al. Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility. Spinal Cord . 2008;46(2):86-95.  doi:10.1038/ sj.sc.3102125.  (RV)"
        },
        {
            "number in article": 20,
            "reference": "Dudley-Javoroski  S, Shields RK. Assessment of physical function and secondary complications after complete spinal cord injury. Disabil Rehabil . 2006;28(2):103-110. doi:10.1080/09638280500163828.  (R)"
        },
        {
            "number in article": 21,
            "reference": "Aidinoff E, Front L, Itzkovich M, et al. Expected spinal cord independence measure, third version, scores for various neurological levels after complete spinal cord lesions. Spinal Cord . 2011;49(8):893-896.  doi:10.1038/sc.2011.32.  (R)"
        },
        {
            "number in article": 22,
            "reference": "Michlovitz SL, Bellew JW, Nolan TP. In: Michlovitz\u2019s Modalities for Therapeutic Intervention . 6th ed. Philadelphia, PA: FA Davis Company; 2016:80-82,  322-323. (GI)"
        },
        {
            "number in article": 23,
            "reference": "Karla V, Sharma S, Sahu J, et al. Childhood acute transverse myelitis: clinical profile, outcome, and association with antiganglioside antibodies. J Child Neurol . 2009;24(4):466-71.  (R)"
        },
        {
            "number in article": 24,
            "reference": "Lee PR, Nath A. Transverse myelitis. In: Cabana MD, ed. The 5-Minute Pediatric Consult Standard . 7th ed. Philadelphia, PA: Wolters Kluwer; 2015:946-947.  (GI)"
        },
        {
            "number in article": 25,
            "reference": "Agarwal V, Shah LM, Parsons MS, et al. Expert panel on neurologic imaging. ACR Appropriateness Criteria: myelopathy. ACR. Guideline Central Web site. https:// acsearch.acr.org/docs/69484/Narrative/ . Published 2020. (G)"
        },
        {
            "number in article": 26,
            "reference": "Harder LL, Holland AA, Frohman E, Graves D, Greenberg BM. Cognitive functioning in pediatric transverse myelitis. Multiple Sclerosis . 2013;19(7):947-952. doi:10.1177/1352458512466606. (R)"
        },
        {
            "number in article": 27,
            "reference": "Grandhe S, Marcus JF, Singhal NS, Gardner M, Waubant EL. Acute transverse myelitis and silent infection with mycoplasma pneumoniae. J Pediatr Neurol . 2014;12(3):145-149.  (C)"
        },
        {
            "number in article": 28,
            "reference": "Fulk GD, Schmitz TJ, Behrman AL. Traumatic spinal cord injury. O'Sullivan SB, Schmitz TJ, Fulk G, eds. Physical Rehabilitation . 7e ed. Philadelphia, PA: McGraw Hill; 2019. (GI)"
        },
        {
            "number in article": 29,
            "reference": "Deiva K, Absoud M, Hemingway C, et al. Acute idiopathic transverse myelitis in children: Early predictors of relapse and disability. Neurology . 2015;84(4):341-349.  doi:10.1212/ WNL.0000000000001179. (R)"
        },
        {
            "number in article": 30,
            "reference": "Meyer P, Leboucq N, Molinari N, et al. Partial acute transverse myelitis is a predictor of multiple sclerosis in children. Mult Scler . 2014;20(11):1485-1493. doi:10.1177/1352458514526943. (R)"
        },
        {
            "number in article": 31,
            "reference": "Rekate HL. Demyelinating disorders of the central nervous system. In: Kliegman RM, Stanton BF, St. Geme JW III, Schor NF, eds. Nelson Textbook of Pediatrics . 21st ed. Philadelphia, PA: Elsevier; 2020:3196-3209.  (GI)"
        },
        {
            "number in article": 32,
            "reference": "Mecharles S, Hermann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet. 2016;387(10026):1481. (C)"
        },
        {
            "number in article": 33,
            "reference": "Regina A, Nelson LS. One last kick\u2014transverse myelitis after an overdose of heroin via insufflation. Emerg Med . 2015;47(10):449-451.  (C)"
        },
        {
            "number in article": 34,
            "reference": "Vadivelu S, Vadivelu S, Mealy M, Patel S, Kosnik-Infinger  L, Becker D. Chiari I malformation in children with transverse myelitis. Dev Neurorehabil . 2018;21(6):402-407. doi:10.1080/17518423.2017.1323972. (G)"
        }
    ]
}